Detalhe da pesquisa
1.
Association between albumin-bilirubin grade and plasma trough concentrations of regorafenib and its metabolites M-2 and M-5 at steady-state in Japanese patients.
Invest New Drugs
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517650
2.
Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor.
Jpn J Clin Oncol
; 54(2): 201-205, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956396
3.
Design, Synthesis, and Biological Evaluation of Water-Soluble Prodrugs of C5-Curcuminoid GO-Y030 Based on Reversible Thia-Michael Reaction.
Chem Pharm Bull (Tokyo)
; 72(1): 127-134, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296515
4.
Lymph-node metastasis from gastric adenocarcinoma in a patient bearing a germ line missense variant MSH2 c.1808A > T (Asp603Val) responds to the immune checkpoint inhibitor pembrolizumab.
Jpn J Clin Oncol
; 53(3): 270-274, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36484308
5.
Recent trends in bone metastasis treatments: A historical comparison using the new Katagiri score system.
World J Clin Cases
; 12(15): 2499-2505, 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817228
6.
A case of hereditary breast and ovarian cancer syndrome of initially presented as cancer of unknown primary with lymph node metastases unveiled by genetic analysis.
Int Cancer Conf J
; 13(2): 139-143, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38524651
7.
Clinical Course of a Rare Epstein-Barr Virus-Associated Smooth Muscle Tumor and Its Genomic Analysis.
Case Rep Oncol
; 16(1): 577-584, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37900829
8.
Pulmonary Artery Intimal Sarcoma in a Patient with Lynch Syndrome: Response to an Immune Checkpoint Inhibitor.
Case Rep Oncol
; 16(1): 21-29, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36743879
9.
Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry.
Case Rep Oncol
; 15(1): 21-26, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35221965
10.
Sudden and severe cardiotoxicity induced with pembrolizumab, its clinical course, therapeutic intervention, and outcome.
Int Cancer Conf J
; 11(1): 81-86, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35127324